Home » Topics » Disease categories and therapies » Immune

Immune
RSS

In vitro and in vivo immunosuppressive effects of FTY-720

Dec. 22, 1997

HHS announces intention to out-license vaccine technology

Dec. 19, 1997

LJP-394 binds to B-cells in lupus patients

Dec. 17, 1997

La Jolla evaluates Toleragan compounds for xenotransplantation

Dec. 17, 1997

SmithKline Beecham licenses rotavirus vaccine

Dec. 16, 1997

Pediatric rotavirus vaccine approval recommended

Dec. 15, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

MedImmune and SKB establish worldwide alliance for HPV vaccines

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Epstein-Barr virus vaccine enters phase I

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...